DE69130571T2 - Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen - Google Patents
Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisenInfo
- Publication number
- DE69130571T2 DE69130571T2 DE69130571T DE69130571T DE69130571T2 DE 69130571 T2 DE69130571 T2 DE 69130571T2 DE 69130571 T DE69130571 T DE 69130571T DE 69130571 T DE69130571 T DE 69130571T DE 69130571 T2 DE69130571 T2 DE 69130571T2
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- immunodeficiency virus
- human immunodeficiency
- inhibit human
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 2
- 208000037357 HIV infectious disease Diseases 0.000 abstract 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 2
- NSVOVKWEKGEOQB-LURJTMIESA-N Gly-Pro-Gly Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(O)=O NSVOVKWEKGEOQB-LURJTMIESA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57108090A | 1990-08-22 | 1990-08-22 | |
| PCT/SE1991/000544 WO1992003147A1 (en) | 1990-08-22 | 1991-08-20 | Peptides that block human immunodeficiency virus infections and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69130571D1 DE69130571D1 (de) | 1999-01-14 |
| DE69130571T2 true DE69130571T2 (de) | 1999-06-17 |
Family
ID=24282265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69130571T Expired - Fee Related DE69130571T2 (de) | 1990-08-22 | 1991-08-20 | Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0545991B1 (de) |
| JP (1) | JP3115596B2 (de) |
| KR (1) | KR100220531B1 (de) |
| AT (1) | ATE173934T1 (de) |
| AU (1) | AU667290B2 (de) |
| BR (1) | BR9106772A (de) |
| CA (1) | CA2088788C (de) |
| DE (1) | DE69130571T2 (de) |
| DK (1) | DK0545991T3 (de) |
| ES (1) | ES2128322T3 (de) |
| FI (1) | FI930519A (de) |
| GR (1) | GR3029523T3 (de) |
| HU (1) | HUT63177A (de) |
| MC (1) | MC2306A1 (de) |
| NO (1) | NO930401L (de) |
| OA (1) | OA10051A (de) |
| WO (1) | WO1992003147A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007204314A1 (en) * | 2006-01-13 | 2007-07-19 | Oncoreg Ab | Use of TPP II inhibitors in combination with gamma-irradiation for the treatment of cancer |
| FR2925501B1 (fr) | 2007-12-21 | 2012-12-14 | Vincience | Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant |
| FR2925500B1 (fr) * | 2007-12-21 | 2011-05-06 | Vincience | Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0245362B1 (de) * | 1985-10-24 | 1994-06-29 | Ronald C. Kennedy | Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc |
| NL8702403A (nl) * | 1987-10-09 | 1989-05-01 | Stichting Centr Diergeneeskund | Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc. |
-
1991
- 1991-08-20 JP JP03514399A patent/JP3115596B2/ja not_active Expired - Fee Related
- 1991-08-20 DK DK91915038T patent/DK0545991T3/da active
- 1991-08-20 HU HU93456A patent/HUT63177A/hu unknown
- 1991-08-20 KR KR1019930700479A patent/KR100220531B1/ko not_active IP Right Cessation
- 1991-08-20 CA CA002088788A patent/CA2088788C/en not_active Expired - Fee Related
- 1991-08-20 AT AT91915038T patent/ATE173934T1/de not_active IP Right Cessation
- 1991-08-20 WO PCT/SE1991/000544 patent/WO1992003147A1/en active IP Right Grant
- 1991-08-20 DE DE69130571T patent/DE69130571T2/de not_active Expired - Fee Related
- 1991-08-20 EP EP91915038A patent/EP0545991B1/de not_active Expired - Lifetime
- 1991-08-20 BR BR919106772A patent/BR9106772A/pt unknown
- 1991-08-20 AU AU84332/91A patent/AU667290B2/en not_active Ceased
- 1991-08-20 MC MC912306D patent/MC2306A1/xx unknown
- 1991-08-20 ES ES91915038T patent/ES2128322T3/es not_active Expired - Lifetime
-
1993
- 1993-02-05 NO NO93930401A patent/NO930401L/no unknown
- 1993-02-05 FI FI930519A patent/FI930519A/fi not_active Application Discontinuation
- 1993-02-17 OA OA60343A patent/OA10051A/en unknown
-
1999
- 1999-03-01 GR GR990400618T patent/GR3029523T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MC2306A1 (fr) | 1993-09-27 |
| GR3029523T3 (en) | 1999-06-30 |
| DE69130571D1 (de) | 1999-01-14 |
| NO930401L (no) | 1993-02-17 |
| EP0545991A1 (de) | 1993-06-16 |
| HUT63177A (en) | 1993-07-28 |
| DK0545991T3 (da) | 1999-08-16 |
| EP0545991B1 (de) | 1998-12-02 |
| AU667290B2 (en) | 1996-03-21 |
| ATE173934T1 (de) | 1998-12-15 |
| AU8433291A (en) | 1992-03-17 |
| ES2128322T3 (es) | 1999-05-16 |
| WO1992003147A1 (en) | 1992-03-05 |
| FI930519A0 (fi) | 1993-02-05 |
| OA10051A (en) | 1996-10-14 |
| NO930401D0 (no) | 1993-02-05 |
| CA2088788C (en) | 2003-12-16 |
| CA2088788A1 (en) | 1992-02-23 |
| JP3115596B2 (ja) | 2000-12-11 |
| BR9106772A (pt) | 1993-07-20 |
| JPH06504035A (ja) | 1994-05-12 |
| KR100220531B1 (ko) | 1999-10-01 |
| FI930519A (fi) | 1993-04-21 |
| HU9300456D0 (en) | 1993-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
| CY1106152T1 (el) | Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids | |
| TR199903053T2 (xx) | Benzimidazol t�revleri. | |
| GB2255093A (en) | Hiv-1 core protein fragments | |
| DE69131200T2 (de) | Herpes simplex virus vp16 impfstoffe | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| IL104780A0 (en) | Sulfonic acid derivatives in the treatment of viral diseases | |
| ATE182271T1 (de) | Arzneimittel zur behandlung von krebs, aids und viruserkrankungen | |
| DE69130571T2 (de) | Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen | |
| FI944561A0 (fi) | HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi | |
| EP0323157A3 (de) | Antivirale Verbindungen und Methoden | |
| PL326629A1 (en) | Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system | |
| DE60143668D1 (de) | Peptidinhibitoren gegen den eintritt von hiv in zellen | |
| CO5160259A1 (es) | Interferon alfa pegilado en la terapia contra el hiv | |
| EP1240899A3 (de) | Regulierung der TH1/TH2 Cytokinexpression durch Ribavirin and Ribavirinanaloge in activierten T-Lymphocyten, zur Behandlung der HCV-Infektionen | |
| HUP0100937A2 (hu) | Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen | |
| ES2160927T3 (es) | Composiciones farmaceuticas que comprenden interferon alfa humano natural. | |
| MY112888A (en) | Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases. | |
| KR900016262A (ko) | 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드 | |
| EP0362755A3 (de) | Humaner zytotoxischer T-Zellen-Klon und Antikörper dagegen | |
| TH13481EX (th) | วัคซีนและวิธีการใช้สำหรับไวรัสภูมิคุ้มกันโรคบกพร่องในมนุษย์ | |
| AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
| SE9502926D0 (sv) | Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it | |
| HRP20030701A2 (en) | Natural antibodies active against hiv virus | |
| FR2709062A1 (fr) | Composition à base de plutonium pour la prévention et le traitement homéopathiques de l'infection par le V.I.H. (virus de l'immunodéficience humaine). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: SYNTELLO VACCINE DEVELOPMENT KB, GOETEBORG, SE |
|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: MAXIM PHARMACEUTICALS,INC., SAN DIEGO, CALIF., US |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: TRIPEP AB, HUDDINGE, SE |
|
| 8339 | Ceased/non-payment of the annual fee |